References
- Monagle, P, et al. Antithrombotic therapy in children. CHEST .
2001;11:344S-370S.
- Centers for Disease Control and Prevention. Trends in Venous
Thromboembolism-Related Pediatric Hospitalizations, 1994-2009.
https://www.cdc.gov/ncbddd/dvt/features/pediatricgenetics-keyfindings-vte.html
Accessed August 2, 2019.
- Boulet SL, Amendah D, Grosse SD, Hooper WC. Health care expenditures
associated with venous thromboembolism among children. Thromb
Res . 2012 May;129(5):583-7. Epub 2011 Aug 26.
- Fernandez MM, Hogue S, Preblick R, Kwong WJ. Review of the cost of
venous thromboembolism. Clinicoecon Outcomes Res .
2015;7:451–462. Published 2015 Aug 28.
- Kufel WD, Seabury RW, Darko W, Probst LA, Miller CD. Clinical
Feasibility of Monitoring Enoxaparin Anti-Xa Concentrations: Are We
Getting It Right?. Hosp Pharm . 2017;52(3):214–220.
- Stutsky, M. E., Reardon, D. P., & Lee, A. I. (2015). Clinical
Practice Patterns of Anti-Xa Monitoring During Low Molecular Weight
Heparin Therapy. Blood, 126(23), 3275. Accessed August 02, 2019.
Retrieved from http://www.bloodjournal.org/content/126/23/3275.
- Garcia, DA, et al. Parental anticoagulants. CHEST .
2016;141:e245-e435.
- Leung M, Ho SH, Hamilton DP, et al. Utility of anti-xa monitoring in
children receiving enoxaparin for therapeutic anticoagulation. J
Pediatr Pharmacol Ther. 2005;10(1):43–50.
- Rosenbloom D, Ginsberg JS. Arguments against monitoring levels of
anti-factor Xa in conjunction with low-molecularweight heparin
therapy. Can J Hosp Pharm 2002;55:15-9.
- Bounameaux, H., De Moerloose, P. Is laboratory monitoring of
low-molecular-weight heparin therapy necessary? No. Journal of
Thrombosis and Haemostasis . 2004;2:551-4
- Enoxaparin. Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc .
Riverwoods, IL. Available at: http://online.lexi.com. Accessed
August 3, 2019.
- Dinh CN, Moffett BS, Galati M, Lee-Kim Y, Yee DL, Mahoney D. A
Critical Evaluation of Enoxaparin Dose Adjustment Guidelines in
Children. J Pediatr Pharmacol Ther. 2019;24(2):128–133.
- Paul A. Harris, Robert Taylor, Robert Thielke, Jonathon Payne,
Nathaniel Gonzalez, Jose G. Conde, Research electronic data capture
(REDCap) - A metadata-driven methodology and workflow process for
providing translational research informatics support, J Biomed Inform.
2009 Apr;42(2):377-81.
- IBM Corp. Released 2010. IBM SPSS Statistics for Windows, Version
19.0. Armonk, NY: IBM Corp.
- Khwaja A. KDIGO clinical practice guidelines for acute kidney
injury. Nephron Clin Pract . 2012;120(4):c179-c184.
- van Ommen CH, Heijboer H, Büller HR, et al. Venous thromboembolism in
childhood: a prospective two-year registry in The Netherlands. J
Pediatr . 2001;139(5):676-681.
- Tuckuviene R, Christensen AL, Helgestad J, et al. Pediatric venous and
arterial noncerebral thromboembolism in Denmark: a nationwide
population-based study. J Pediatr . 2011;159(4):663-669.
- Takemoto CM, Sohi S, Desai K, et al. Hospital-associated venous
thromboembolism in children: incidence and clinical
characteristics. J Pediatr . 2014;164(2):332-338.
- Lee YR, Vega JA, Duong HN, et al. Monitoring Enoxaparin with
Antifactor Xa Levels in Obese Patients. Pharmacotherapy .
2015;35(11):1007-1015.
- Ahuja T, Mousavi KM, Klejmont L, et al. Enoxaparin Dosing and AntiXa
Monitoring in Specialty Populations: A Case Series of Renal-Impaired,
Extremes of Body Weight, Pregnant, and Pediatric Patients. P T .
2018;43(10):609-614.